GlassScriptPhysician profile
Manish Shah
NPI 1962792986
$6,615.34
in general payments reported to CMS, 2019-2025
29 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $993 · 2021: $60.08 · 2022: $1,028 · 2023: $1,374 · 2024: $1,000 · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,398 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,397.80 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,267.63 | 2019-2025 | Eterna, Proclaim, Octrode |
| Vertos Medical, INC. | $1,168.67 | 2020-2024 | Mild Device Kit |
| Nevro Corp. | $1,110.86 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,006.26 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Spectra Wavewriter |
| Merit Medical Systems INC | $700.00 | 2025 | Star Tumor Ablation System |
| Spinal Simplicity, LLC | $168.00 | 2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $141.43 | 2025 | Senza |
| Abbvie INC. | $125.69 | 2022-2025 | |
| Stryker Corporation | $117.42 | 2024 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $103.04 | 2023-2025 | |
| Relievant Medsystems, INC. | $86.60 | 2022 | |
| Medtronic, INC. | $84.09 | 2024 | Intellis Adaptivestim |
| Tersera Therapeutics LLC | $72.72 | 2023-2025 | Prialt |
| Ibsa Pharma INC. | $69.38 | 2023-2024 | Tirosint, Licart, Licart |
| Scpharmaceuticals INC. | $49.03 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sentynl Therapeutics, INC. | $37.40 | 2019 | |
| Mml US, INC. | $36.62 | 2023 | Reactiv8 |
| Biotronik Nro, INC. | $35.48 | 2025 | Prospera |
| Medtronic USA, INC. | $35.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $30.14 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Nalu Medical, INC. | $26.02 | 2025 | Nalu Neurostimulation System |
| Zyla Life Sciences, INC. | $24.58 | 2019 | |
| Si-Bone, INC. | $22.16 | 2024 | |
| Saluda Medical Americas, INC. | $19.87 | 2025 | Evoke |
| Janssen Biotech, INC. | $18.25 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.96 | 2023 | Relistor |
| Almatica Pharma LLC | $14.68 | 2022 | |
| Pacira Therapeutics, INC. | $14.58 | 2019 | |
| Horizon Therapeutics Plc | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.